Elmwood Wealth Management, Inc. Amgen Inc Transaction History

Elmwood Wealth Management, Inc.

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$198.88 - $227.6 $24,860 - $28,450	-125 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$221.91 - $258.6 $665 - $775	3 Added 2.46%	125 $31,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $2,769 - $3,398	14 Added 12.96%	122 $29,000
Q1 2020 May 12, 2020	BUY	$182.24 - $241.7 $19,681 - $26,103	108 New	108 $21,000
Q4 2019 Feb 05, 2020	SELL	$189.21 - $243.2 $21,191 - $27,238	-112 Closed	0 $0
Q3 2019 Nov 13, 2019	BUY	$174.11 - $208.62 $174 - $208	1 Added 0.9%	112 $22,000
Q1 2019 May 22, 2019	BUY	$180.87 - $203.88 $180 - $203	1 Added 0.91%	111 $21,000
Q3 2018 Oct 11, 2018	BUY	$185.29 - $208.89 $185 - $208	1 Added 0.92%	110 $22.7 Million
Q2 2018 Aug 22, 2018	BUY	$166.05 - $186.51 $166 - $186	1 Added 0.93%	109 $20.1 Million
Q1 2018 May 10, 2018	BUY	$169.43 - $198.0 $18,298 - $21,384	108 New	108 $18.5 Million

3,122

410M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $155B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Elmwood Wealth Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Elmwood Wealth Management, Inc. with notifications on news.